ALFA Filings
Every announcement, straight from the exchange
Every AstraZeneca Pharma India other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements with these filters
NSE Sustainability Ratings and Analytics assigned AstraZeneca Pharma India an ESG rating of 73 for FY 2025-26. The rating was independently prepared without company engagement.
AstraZeneca Pharma India reported receiving an ESG rating of 64 from Crisil ESG Ratings. The assessment was independently prepared using publicly available information.
AstraZeneca Pharma India has been assigned an ESG rating of 57 by Crisil ESG Ratings based on publicly available information.